ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1810

Evaluation Of The New American College Of Rheumatology/European League Against Rheumatism Criteria For The Classification Of Systemic Sclerosis In The Canadian Scleroderma Research Group Cohort

Hebah Alhajeri1, Marie Hudson2, Marvin J. Fritzler3, Janet E. Pope4, Canadian Scleroderma Research Group -5 and Murray Baron6, 1Rheumatology, McGill University, Montreal, QC, Canada, 2Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 3Medicine, University of Calgary, Calgary, AB, Canada, 4St Joseph Health Care, London, ON, Canada, 5Jewish General Hospital, Montreal, QC, Canada, 6Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: classification criteria, scleroderma and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics II

Session Type: Abstract Submissions (ACR)

Background/Purpose: New classification criteria for systemic sclerosis (SSc) have recently been developed. In this study, we aimed to assess the sensitivity of this classification in the patients in the Canadian Scleroderma Research Group (CSRG) cohort.

Methods: SSc patients are included in the CSRG cohort if they have a diagnosis of SSc according to a rheumatologist. The 1980 Preliminary Classification Criteria for systemic sclerosis and the new ACR/EULAR classification criteria were applied. The sensitivity of each criterion in diagnosing SSc was calculated and compared across different socio-demographic and clinical categories.

Results: A total of 1115 SSc patients were included in the study. The majority were females (86%). Overall, the sensitivity of the new criteria was higher (98.4%) than that of the 1980 criteria (87.7%). This pattern was consistent among a number of sub-groups. The new criteria detected 691 (97.5%) of the limited SSc patients whereas the 1980 criteria detected only 572 (80.7%) of limited SSc patients. Both criteria detected 100% of patients with diffuse SSc. Ninety nine percent of anti-centromere (ACA) positive patients were detected by the new criteria, whereas the sensitivity of the 1980 criteria was 78.6% in this category. The sensitivities of new and 1980 criteria were 98.1% and 92.2% respectively in negative ACA category. In patients with disease duration ² 3 years, the sensitivity of the new criteria was 98.8% whereas the sensitivity of 1980 criteria was 87.2%. In patients with disease duration > 3 years, the sensitivities of new and 1980 criteria were 98.3% and 87.9% respectively. When we compared the sensitivities according to age at disease onset, we found that the new criteria had a higher sensitivity than the 1980 criteria, 98.6% and 88.8% respectively, for age of onset of ² 50 years and 98% and 85.8% respectively for age of onset > 50 years. The sensitivity of the new criteria were much higher than the 1980 criteria in the ACA positive and disease duration ² 3 years group, 96.9% versus 67.7%, respectively. For patients with disease duration > 3 years and positive ACA, sensitivities were 99.3% versus 81.2% for new and 1980 criteria, respectively. In patients with negative ACA and disease duration ² 3 years, the sensitivity of the new criteria was 99.4% while the sensitivity of 1980 criteria were 95%. Ninety eight percent of patients with negative ACA and disease duration > 3 years were detected using the new criteria, compared with 91.3% for the 1980 criteria in the same group.

Conclusion: Overall, the new classification criteria for SSc are substantially more sensitive than the 1980 criteria. This applies to both sexes, recent or longstanding disease and either young or older subjects. The improvement in sensitivity is most striking, however, in limited SSc or in those with ACA and especially in those with recent onset ACA positive disease.


Disclosure:

H. Alhajeri,
None;

M. Hudson,
None;

M. J. Fritzler,
None;

J. E. Pope,
None;

C. S. R. G. –,
None;

M. Baron,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-the-new-american-college-of-rheumatologyeuropean-league-against-rheumatism-criteria-for-the-classification-of-systemic-sclerosis-in-the-canadian-scleroderma-research-group-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology